Custom Index Systems, LLC Argenx Se Call Options Transaction History
Custom Index Systems, LLC
- $197 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARGX
# of Institutions
475Shares Held
28.7MCall Options Held
308KPut Options Held
239K-
Price T Rowe Associates Inc Baltimore, MD5.38MShares$3.02 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.56 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.14MShares$1.2 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.94MShares$1.09 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$693 Million11.83% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $31B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...